Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Lanzillo

Showing results (81-90 of 210) with videos related to

Pageof 21
Sort By:
Brain and Language|August 16, 2018
Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junctionAntonio Carotenuto, Sirio Cocozza, Mario Quarantelli, et al.
Neuroradiology|February 20, 2024
The impact of image contrast, resolution and reader expertise on black hole identification in Multiple SclerosisMario Tranfa, Alessandra Scaravilli, Chiara Pastore, et al.
Journal of Neurology|May 22, 2024
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosisIsabel Monteiro, Valerio Nicolella, Mariano Fiorenza, et al.
Multiple Sclerosis and Related Disorders|September 28, 2021
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trialMaria Petracca, Mario Quarantelli, Marcello Moccia, et al.
International Journal of Environmental Research and Public Health|May 17, 2020
Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015-2017 PrevalenceMarcello Moccia, Vincenzo Brescia Morra, Roberta Lanzillo, et al.
Journal of Neurology|December 1, 2018
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairmentRosario Megna, Bruno Alfano, Roberta Lanzillo, et al.
Therapeutic Advances in Neurological Disorders|March 1, 2019
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosisMarcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
Neurology International|April 26, 2024
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based StudyMarcello Moccia, Giuseppina Affinito, Giuseppina Marrazzo, et al.
Multiple Sclerosis and Related Disorders|July 1, 2023
Exploring the relation between reserve and fatigue in multiple sclerosisMario Tranfa, Valentina Virginia Iuzzolino, Pierpaolo Perrella, et al.
International Journal of Molecular Sciences|December 11, 2022
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of LiteratureAntonio Luca Spiezia, Antonio Carotenuto, Aniello Iovino, et al.
Pageof 21

Showing results (81-90 of 210) with videos related to

Sort By:
Pageof 21
Brain and Language|August 16, 2018
Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junctionAntonio Carotenuto, Sirio Cocozza, Mario Quarantelli, et al.
Neuroradiology|February 20, 2024
The impact of image contrast, resolution and reader expertise on black hole identification in Multiple SclerosisMario Tranfa, Alessandra Scaravilli, Chiara Pastore, et al.
Journal of Neurology|May 22, 2024
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosisIsabel Monteiro, Valerio Nicolella, Mariano Fiorenza, et al.
Multiple Sclerosis and Related Disorders|September 28, 2021
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trialMaria Petracca, Mario Quarantelli, Marcello Moccia, et al.
International Journal of Environmental Research and Public Health|May 17, 2020
Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015-2017 PrevalenceMarcello Moccia, Vincenzo Brescia Morra, Roberta Lanzillo, et al.
Journal of Neurology|December 1, 2018
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairmentRosario Megna, Bruno Alfano, Roberta Lanzillo, et al.
Therapeutic Advances in Neurological Disorders|March 1, 2019
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosisMarcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
Neurology International|April 26, 2024
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based StudyMarcello Moccia, Giuseppina Affinito, Giuseppina Marrazzo, et al.
Multiple Sclerosis and Related Disorders|July 1, 2023
Exploring the relation between reserve and fatigue in multiple sclerosisMario Tranfa, Valentina Virginia Iuzzolino, Pierpaolo Perrella, et al.
International Journal of Molecular Sciences|December 11, 2022
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of LiteratureAntonio Luca Spiezia, Antonio Carotenuto, Aniello Iovino, et al.
Pageof 21